FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019915273> ?p ?o ?g. }

• W2019915273 endingPage "1166" @default.
• W2019915273 startingPage "1156" @default.
• W2019915273 abstract "Estrogens are important mediators of bone homeostasis, and postmenopausal estrogen replacement therapy is extensively used to prevent osteoporosis. The biological effects of estrogen are mediated by receptors belonging to the superfamily of steroid/thyroid nuclear receptors, estrogen receptor (ER)alpha and ER beta. ER alpha, not only trans-activates target genes in a hormone-specific fashion, but it can also neutralize other transcriptional activators, such as nuclear factor (NF)-kappa B, causing repression of their target genes. A major mechanism by which estrogens prevent osteoporosis seems to be repression of transcription of NF-kappa B target genes, such as the osteoclast-activating cytokines interleukin-6 and interleukin-1. To study the capacity of both ERs in repression of NF-kappa B signaling in bone cells, we first carried out transient transfections with ER alpha or ER beta of the human osteoblastic U2-OS cell line, in which endogenous NF-kappa B was stimulated by tumor necrosis factor alpha. Repression by ER alpha was already observed without 17 beta-estradiol, whereas addition of the ligand increased repression to 90%. ER beta, however, was able to repress NF-kappa B activity only in the presence of ligand. Because it is known that some antiestrogens can also display tissue-specific agonistic properties, 4-hydroxytamoxifen was tested for its capacity in repressing NF-kappa B activity and was found to be active (albeit less efficient than 17 beta-estradiol) and, interestingly, only with ER alpha. The pure antagonist ICI 164,384 was incapable of repressing through any ER subtypes. Deletion analysis and the use of receptor ER alpha/ER beta-chimeras showed that the A/B domain, containing activation function-1, is essential for this suppressive action. Next, we developed stable transfectants of the human osteoblastic U2-OS cell line containing ER alpha or ER beta in combination with an NF-kappa B luciferase reporter construct. In these cell lines, repression of NF-kappa B activity was only mediated through ER alpha and not through ER beta. These findings offer new insights into the specific role of both ER subtypes in bone homeostasis and could eventually help in developing more specific medical intervention strategies for osteoporosis." @default.
• W2019915273 created "2016-06-24" @default.
• W2019915273 creator A5027062796 @default.
• W2019915273 creator A5036193907 @default.
• W2019915273 creator A5039573251 @default.
• W2019915273 creator A5041033639 @default.
• W2019915273 creator A5056892374 @default.
• W2019915273 creator A5057109898 @default.
• W2019915273 creator A5072385110 @default.
• W2019915273 date "2001-03-01" @default.
• W2019915273 modified "2023-10-16" @default.
• W2019915273 title "4-Hydroxytamoxifen Trans-Represses Nuclear Factor-κB Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER)α, and Not through ERβ*" @default.
• W2019915273 cites W1522773084 @default.
• W2019915273 cites W1541234884 @default.
• W2019915273 cites W1549372639 @default.
• W2019915273 cites W1566472466 @default.
• W2019915273 cites W1591317354 @default.
• W2019915273 cites W1717444875 @default.
• W2019915273 cites W1723187988 @default.
• W2019915273 cites W1907620665 @default.
• W2019915273 cites W1971767029 @default.
• W2019915273 cites W1971807925 @default.
• W2019915273 cites W1971960644 @default.
• W2019915273 cites W1981874801 @default.
• W2019915273 cites W1986004201 @default.
• W2019915273 cites W1997883187 @default.
• W2019915273 cites W2003991752 @default.
• W2019915273 cites W2007762330 @default.
• W2019915273 cites W2008050502 @default.
• W2019915273 cites W2012537034 @default.
• W2019915273 cites W2015789469 @default.
• W2019915273 cites W2016669417 @default.
• W2019915273 cites W2042859356 @default.
• W2019915273 cites W2045673939 @default.
• W2019915273 cites W2049970571 @default.
• W2019915273 cites W2054267961 @default.
• W2019915273 cites W2068076267 @default.
• W2019915273 cites W2068527957 @default.
• W2019915273 cites W2072231974 @default.
• W2019915273 cites W2073353512 @default.
• W2019915273 cites W2073883348 @default.
• W2019915273 cites W2077635867 @default.
• W2019915273 cites W2081540673 @default.
• W2019915273 cites W2087407206 @default.
• W2019915273 cites W2100907853 @default.
• W2019915273 cites W2101738855 @default.
• W2019915273 cites W2101833345 @default.
• W2019915273 cites W2111650618 @default.
• W2019915273 cites W2128840922 @default.
• W2019915273 cites W2144345410 @default.
• W2019915273 cites W2151888740 @default.
• W2019915273 cites W2151892297 @default.
• W2019915273 cites W2158868674 @default.
• W2019915273 cites W2159674010 @default.
• W2019915273 cites W2161623422 @default.
• W2019915273 cites W2193981851 @default.
• W2019915273 cites W2313507666 @default.
• W2019915273 cites W2321613759 @default.
• W2019915273 cites W2615633554 @default.
• W2019915273 cites W4294216491 @default.
• W2019915273 cites W994887766 @default.
• W2019915273 doi "https://doi.org/10.1210/endo.142.3.8003" @default.
• W2019915273 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11181531" @default.
• W2019915273 hasPublicationYear "2001" @default.
• W2019915273 type Work @default.
• W2019915273 sameAs 2019915273 @default.
• W2019915273 citedByCount "63" @default.
• W2019915273 countsByYear W20199152732013 @default.
• W2019915273 countsByYear W20199152732014 @default.
• W2019915273 countsByYear W20199152732015 @default.
• W2019915273 countsByYear W20199152732017 @default.
• W2019915273 countsByYear W20199152732018 @default.
• W2019915273 countsByYear W20199152732019 @default.
• W2019915273 countsByYear W20199152732021 @default.
• W2019915273 countsByYear W20199152732022 @default.
• W2019915273 countsByYear W20199152732023 @default.
• W2019915273 crossrefType "journal-article" @default.
• W2019915273 hasAuthorship W2019915273A5027062796 @default.
• W2019915273 hasAuthorship W2019915273A5036193907 @default.
• W2019915273 hasAuthorship W2019915273A5039573251 @default.
• W2019915273 hasAuthorship W2019915273A5041033639 @default.
• W2019915273 hasAuthorship W2019915273A5056892374 @default.
• W2019915273 hasAuthorship W2019915273A5057109898 @default.
• W2019915273 hasAuthorship W2019915273A5072385110 @default.
• W2019915273 hasBestOaLocation W20199152731 @default.
• W2019915273 hasConcept C104317684 @default.
• W2019915273 hasConcept C121608353 @default.
• W2019915273 hasConcept C126322002 @default.
• W2019915273 hasConcept C134018914 @default.
• W2019915273 hasConcept C150194340 @default.
• W2019915273 hasConcept C170493617 @default.
• W2019915273 hasConcept C172313692 @default.
• W2019915273 hasConcept C185592680 @default.
• W2019915273 hasConcept C186310378 @default.
• W2019915273 hasConcept C2777164284 @default.
• W2019915273 hasConcept C530470458 @default.
• W2019915273 hasConcept C55493867 @default.
• W2019915273 hasConcept C63932345 @default.

• next